针对猪繁殖与呼吸综合征病毒和猪肺炎支原体的候选多表位疫苗在小鼠中诱导强烈的体液和细胞免疫应答
本研究筛选猪繁殖与呼吸综合征病毒(PRRSV)GP5、M蛋白及猪肺炎支原体(Mhp)P46、P65蛋白的B细胞和T细胞表位,构建重组表位蛋白rEP-PM,并在小鼠中评估免疫效果。结果显示rEP-PM可诱导高水平抗体,与抗rEP-PM、抗PRRSV和抗Mhp抗体具有良好免疫反应性,且诱导以Th1为主的细胞免疫应答。作者认为rEP-PM可能是开发安全有效的多表位联合疫苗的候选蛋白。
要点
- rEP-PM由PRRSV-GP5、PRRSV-M、Mhp-P46和Mhp-P65蛋白的B细胞及T细胞表位构建而成。
- rEP-PM免疫小鼠后可诱导高水平抗体产生。
- rEP-PM在小鼠中诱导以Th1为主的细胞免疫应答。
核心结论
- 作者认为rEP-PM蛋白可能是开发安全有效的多表位肽联合疫苗以控制PRRSV和Mhp感染的潜在候选。
研究设计与样本
- 本研究筛选PRRSV-GP5、PRRSV-M、Mhp-P46和Mhp-P65蛋白的B细胞和T细胞表位,构建重组表位蛋白rEP-PM,并在小鼠中进行免疫评价。
主要发现
- rEP-PM具有良好亲水性、强抗原性和高表面可及性,且每个表位独立完整。
- rEP-PM免疫小鼠后可诱导高水平抗体产生,并与抗rEP-PM、抗PRRSV和抗Mhp抗体具有良好免疫反应性。
- 抗rEP-PM抗体可特异性识别来自PRRSV和Mhp的蛋白。
- rEP-PM在小鼠中诱导以Th1为主的细胞免疫应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Porcine reproductive and respiratory syndrome virus (PRRSV) and Mycoplasma hyopneumoniae (M. hyopneumoniae, Mhp) are two of the most common pathogens involved in the porcine respiratory disease complex (PRDC) resulting in significant economic losses worldwide. Vaccination is the most effective approach to disease prevention. Since PRRSV and Mhp co-infections are very common, an efficient dual vaccine against these pathogens is required for the global swine industry. Compared with traditional vaccines, multi-epitope vaccines have several advantages, they are comparatively easy to produce and construct, are chemically stable, and do not have an infectious potential. In this study, to develop a safe and effective vaccine, B cell and T cell epitopes of PRRSV-GP5, PRRSV-M, Mhp-P46, and Mhp-P65 protein had been screened to construct a recombinant epitope protein rEP-PM that has good hydrophilicity, strong antigenicity, and high surface accessibility, and each epitope is independent and complete. After immunization in mice, rEP-PM could induce the production of high levels of antibodies, and it had good immunoreactivity with anti-rEP-PM, anti-PRRSV, and anti-Mhp antibodies. The anti-rEP-PM antibody specifically recognizes proteins from PRRSV and Mhp. Moreover, rEP-PM induced a Th1-dominant cellular immune response in mice. Our results showed that the rEP-PM protein could be a potential candidate for the development of a safe and effective multi-epitope peptide combined vaccine to control PRRSV and Mhp infections.
引用
- Gao Z, Chen L, Song T, et al. A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice. Vaccine. 2022. PMID: 35307227. doi:10.1016/j.vaccine.2022.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。